Richard Hill, MD
Urogynecology and Reconstructive Pelvic Surgery · Kansas City, MONPI 1144212424
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,351 of the $2,824 with a category attached, or 83.3%. Axonics, Inc. accounts for 60.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $777 and has fallen 66.1% since, to $263 in 2025.
Across 58 payments — averaging $48.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$2K
- Boston Scientific$523
- Coloplast$294
- Caldera Medical, Inc$172
- AbbVie$91
- Valencia Technologies Corporation$37
What the payments were for
- Speaking & faculty fees$47317%
- Food & beverage$2,35183%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 32 | $1,707 |
| Boston Scientific | 10 | $523 |
| Coloplast | 4 | $294 |
| Caldera Medical, Inc | 5 | $172 |
| AbbVie | 5 | $91 |
| Valencia Technologies Corporation | 2 | $37 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics r-SNM System$770
- Axonics$469
- ALTIS$261
- Desara$124
- SOLYX$113
How this compares
$2,824 in reported general payments places this provider in the 60th percentile of 21 urogynecology and reconstructive pelvic surgery providers in Missouri.
See all urogynecology and reconstructive pelvic surgery providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 85 | $59,861 |
| Estradiol | 200 | $13,567 |
| GemtesaVibegron | 17 | $13,526 |
| Methenamine Hippurate | 133 | $12,063 |
| PremarinEstrogens, Conjugated | 27 | $11,057 |
| Solifenacin Succinate | 84 | $4,903 |
| Tolterodine Tartrate ErTolterodine Tartrate | 24 | $2,041 |
| Oxybutynin Chloride ErOxybutynin Chloride | 136 | $1,834 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 13 | $1,390 |
| Clobetasol Propionate | 23 | $1,339 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 82 | $1,137 |
| Trospium Chloride | 14 | $1,105 |
| Halobetasol Propionate | 17 | $1,096 |
| Cephalexin | 143 | $761 |
| Tamsulosin Hcl | 81 | $693 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Kansas City
- Stephen WassingerKansas City$3K
- Nia JenkinsKansas City$3K
- Gisella NewberyKansas City$324
- Kent BurkKansas City$100
- Elizabeth WilliamsSt. Louis$195K
- Denicia DwaricaColumbia$19K
- Dionysios VeronikisSaint Louis$6K
- Raymond FosterColumbia$6K
- Ian RosbrughNorth Kansas City$5K
- Jerry LowderSaint Louis$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.